Philips Issues Correction for Trilogy Evo Ventilators Following FDA Class I Recall
The Food and Drug Administration identifies the software update and nebulizer restrictions as the most serious type of recall.
The Food and Drug Administration identifies the software update and nebulizer restrictions as the most serious type of recall.
Olympus has updated use instructions after reports that the ligation loop may not release as expected, potentially requiring emergency intervention.
The action addresses a discrepancy between the device's labeled and actual performance at high flow rates, which could pose a risk of patient hypothermia.
The Food and Drug Administration identifies the software update and nebulizer restrictions as the most serious type of recall.
The most serious type of recall was initiated due to a blocked manometer port, which can prevent pressure monitoring and lead to severe patient harm.
Read MoreA software flaw that may cause the Plum Duo Infusion System to become unresponsive has prompted a device correction, which the FDA has identified as its most serious recall type.
Read MoreThe FDA has issued a Class I recall designation for the correction, which addresses a fault that can cause ventilation to stop unexpectedly.
Read MoreBoston Scientificās Endotak Reliance leads with ePTFE-coated coils may reduce shock efficacy due to coil calcification.
Read MoreUpdated guidance addresses ventilator inoperative alarm failures that may lead to therapy loss, with 13 injuries and eight deaths reported.
Read MoreThe FDA issued an early alert under its recall communications pilot citing 79 injuries and two deaths linked to Baxterās Novum IQ infusion pump.
Read More
The voluntary recall involves pump modules that may have been repaired with FR-110 bezels, which the company says can weaken over time and compromise safe infusion delivery.